S1PR5
Basic information
Region (hg38): 19:10512742-10517931
Previous symbols: [ "EDG8" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the S1PR5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 22 | 24 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 5 | 3 |
Variants in S1PR5
This is a list of pathogenic ClinVar variants found in the S1PR5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-10513832-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
19-10513834-G-C | Likely benign (Jul 16, 2018) | |||
19-10513905-C-G | not specified | Uncertain significance (May 26, 2024) | ||
19-10513939-C-T | not specified | Uncertain significance (Jun 30, 2023) | ||
19-10514017-G-A | not specified | Likely benign (Jun 18, 2021) | ||
19-10514028-G-A | Likely benign (May 01, 2022) | |||
19-10514089-A-T | Benign (Jul 16, 2018) | |||
19-10514110-A-G | not specified | Uncertain significance (Sep 14, 2022) | ||
19-10514182-C-A | not specified | Uncertain significance (Dec 19, 2023) | ||
19-10514187-C-T | Benign (Jul 23, 2018) | |||
19-10514192-C-A | not specified | Uncertain significance (Jul 14, 2021) | ||
19-10514309-T-C | not specified | Uncertain significance (May 15, 2024) | ||
19-10514326-C-T | not specified | Uncertain significance (Mar 01, 2023) | ||
19-10514329-G-A | not specified | Uncertain significance (Dec 26, 2023) | ||
19-10514368-A-C | not specified | Uncertain significance (Dec 21, 2022) | ||
19-10514381-G-C | not specified | Uncertain significance (Sep 28, 2022) | ||
19-10514414-C-G | not specified | Uncertain significance (Nov 28, 2023) | ||
19-10514445-G-A | Benign (Jun 14, 2018) | |||
19-10514476-A-G | not specified | Uncertain significance (Oct 13, 2023) | ||
19-10514504-C-A | not specified | Uncertain significance (Jun 07, 2024) | ||
19-10514563-C-A | not specified | Uncertain significance (Sep 17, 2021) | ||
19-10514583-C-T | Likely benign (May 17, 2018) | |||
19-10514585-C-T | not specified | Uncertain significance (Jan 04, 2022) | ||
19-10514589-C-T | Benign/Likely benign (May 01, 2022) | |||
19-10514627-T-C | not specified | Uncertain significance (Feb 21, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
S1PR5 | protein_coding | protein_coding | ENST00000439028 | 1 | 4985 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.157 | 0.782 | 125044 | 0 | 8 | 125052 | 0.0000320 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.45 | 199 | 266 | 0.749 | 0.0000166 | 2392 |
Missense in Polyphen | 65 | 102.58 | 0.63362 | 1039 | ||
Synonymous | 1.34 | 117 | 137 | 0.855 | 0.00000897 | 982 |
Loss of Function | 1.53 | 2 | 6.08 | 0.329 | 2.62e-7 | 63 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000472 | 0.0000462 |
European (Non-Finnish) | 0.0000675 | 0.0000621 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for the lysosphingolipid sphingosine 1- phosphate (S1P). S1P is a bioactive lysophospholipid that elicits diverse physiological effect on most types of cells and tissues. Is coupled to both the G(i/0)alpha and G(12) subclass of heteromeric G-proteins (By similarity). May play a regulatory role in the transformation of radial glial cells into astrocytes and may affect proliferative activity of these cells. {ECO:0000250}.;
- Pathway
- Sphingolipid signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Signal Transduction of S1P Receptor;Signaling by GPCR;Signal Transduction;Lysosphingolipid and LPA receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;S1P5 pathway;G alpha (i) signalling events;GPCR downstream signalling;S1P4 pathway;Sphingosine 1-phosphate (S1P) pathway
(Consensus)
Recessive Scores
- pRec
- 0.120
Intolerance Scores
- loftool
- 0.105
- rvis_EVS
- 0.62
- rvis_percentile_EVS
- 83.25
Haploinsufficiency Scores
- pHI
- 0.0946
- hipred
- N
- hipred_score
- 0.438
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.447
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- S1pr5
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- sphingosine-1-phosphate receptor signaling pathway;G protein-coupled receptor signaling pathway;regulation of neuron differentiation
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- sphingosine-1-phosphate receptor activity